Trial Design and Optimal Determination of CNS Activity of Small Molecule Targeted Therapy in NSCLC.
Jennings EM, Camidge DR, Gadgeel S, Barker S. Trial Design and Optimal Determination of CNS Activity of Small Molecule Targeted Therapy in NSCLC. Clin Lung Cancer. 2024 03; 25(2):91-99.